Spyre Therapeutics, Inc. (SYRE)
NASDAQ: SYRE · Real-Time Price · USD
100.23
+6.11 (6.49%)
At close: Jul 17, 2026, 4:00 PM EDT
100.00
-0.23 (-0.23%)
After-hours: Jul 17, 2026, 6:52 PM EDT

Spyre Therapeutics Analyst Ratings

Ratings History

AnalystFirmRatingRatingActionPrice TargetUpsideDate
LifeSci Capital
LifeSci Capital
Buy
Reiterates
$119
BuyReiterates$119+18.73%Jul 9, 2026
BTIG
BTIG
Buy
Maintains
$112
BuyMaintains$112+11.74%Jul 6, 2026
Jefferies
Jefferies
Buy
Maintains
$98
BuyMaintains$98-2.22%Jun 30, 2026
Deutsche Bank
Deutsche Bank
Buy
Maintains
$115$135
BuyMaintains$115$135+34.69%Jun 23, 2026
TD Cowen
TD Cowen
Buy
Maintains
n/a
BuyMaintainsn/an/aJun 23, 2026
Stifel Nicolaus
Stifel Nicolaus
Buy
Reiterates
$107
BuyReiterates$107+6.75%Jun 22, 2026
Wedbush
Wedbush
Buy
Maintains
$80$100
BuyMaintains$80$100-0.23%Jun 16, 2026
JonesTrading
JonesTrading
Buy
Reiterates
$95$104
BuyReiterates$95$104+3.76%Jun 14, 2026

Upgrade to Pro

Get stock forecasts from Wall Street's highest rated professionals

Get much more with Stock Analysis Pro

  • Investment ideas from the top Wall Street analysts
  • Unlimited access to all data and tools
  • Advanced analyst filtering and sorting options
  • Up to 3 years of analyst rating history
Sign Up Today

Analyst Star Rankings

Our analyst star rankings are based on these four factors

Success Rate
The percentage of ratings that are profitable.
Average Return
The average percentage return within one year of the rating.
Rating Count
The more ratings the analyst has provided, the higher the score.
Recency
Ratings provided within the past year contribute to a higher score.